
Envista Holdings Corporation NVST
$ 25.98
-1.96%
Annual report 2025
added 02-12-2026
Envista Holdings Corporation Total Inventories 2011-2026 | NVST
Annual Total Inventories Envista Holdings Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 288 M | 241 M | 259 M | 301 M | 264 M | 267 M | 278 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 301 M | 241 M | 271 M |
Quarterly Total Inventories Envista Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 282 M | 261 M | 241 M | 266 M | 264 M | 267 M | 259 M | 279 M | 297 M | 307 M | 301 M | 291 M | - | 280 M | 264 M | 274 M | 312 M | 283 M | 216 M | 216 M | 267 M | 267 M | 278 M | 278 M | 278 M | 278 M | 279 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 312 M | 216 M | 272 M |
Total Inventories of other stocks in the Medical instruments industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
82.3 M | - | - | $ 810 M | ||
|
Ekso Bionics Holdings
EKSO
|
4.82 M | $ 11.16 | -0.49 % | $ 27.1 M | ||
|
ICU Medical
ICUI
|
616 M | $ 116.04 | -4.11 % | $ 2.86 B | ||
|
The Cooper Companies
COO
|
846 M | $ 62.28 | -1.28 % | $ 12.4 B | ||
|
Microbot Medical
MBOT
|
584 K | $ 2.05 | -2.6 % | $ 93.9 M | ||
|
Milestone Scientific
MLSS
|
3.78 M | $ 0.3 | -8.8 % | $ 24.6 M | ||
|
iRhythm Technologies
IRTC
|
21.6 M | $ 121.29 | -3.31 % | $ 3.88 B | ||
|
Haemonetics Corporation
HAE
|
365 M | $ 59.07 | -1.14 % | $ 2.97 B | ||
|
electroCore
ECOR
|
1.63 M | $ 6.25 | 1.63 % | $ 53 K | ||
|
Pulse Biosciences
PLSE
|
136 K | $ 20.99 | -3.85 % | $ 1.41 B | ||
|
Repro Med Systems
KRMD
|
3.68 M | $ 4.03 | -1.23 % | $ 186 M | ||
|
Isoray
ISR
|
980 K | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
1.84 B | $ 450.66 | -3.43 % | $ 161 B | ||
|
STAAR Surgical Company
STAA
|
15.7 M | $ 25.96 | -2.77 % | $ 1.29 B | ||
|
Glaukos Corporation
GKOS
|
42 M | $ 115.82 | -3.23 % | $ 5.61 B | ||
|
STERIS plc
STE
|
581 M | $ 211.72 | -3.82 % | $ 20.9 B | ||
|
Teleflex Incorporated
TFX
|
404 M | $ 135.79 | 0.21 % | $ 6.06 B | ||
|
Masimo Corporation
MASI
|
459 M | $ 178.45 | -0.03 % | $ 9.51 B | ||
|
InfuSystem Holdings
INFU
|
4.82 M | $ 9.83 | -3.44 % | $ 203 M | ||
|
Merit Medical Systems
MMSI
|
334 M | $ 64.63 | -3.16 % | $ 3.82 B | ||
|
Utah Medical Products
UTMD
|
7.94 M | $ 66.05 | -0.85 % | $ 214 M | ||
|
West Pharmaceutical Services
WST
|
444 M | $ 294.0 | 0.68 % | $ 21.3 B | ||
|
DENTSPLY SIRONA
XRAY
|
642 M | $ 11.49 | -2.5 % | $ 2.29 B | ||
|
Retractable Technologies
RVP
|
17.2 M | $ 0.62 | -3.12 % | $ 18.6 M | ||
|
Pro-Dex
PDEX
|
22.2 M | $ 50.62 | -1.73 % | $ 166 M | ||
|
LeMaitre Vascular
LMAT
|
19.6 M | $ 109.67 | -2.43 % | $ 2.48 B | ||
|
Predictive Oncology
POAI
|
481 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
29 M | $ 20.33 | -2.73 % | $ 937 M | ||
|
Stereotaxis
STXS
|
9.57 M | $ 1.78 | -4.56 % | $ 162 M | ||
|
Baxter International
BAX
|
2.23 B | $ 16.99 | -5.35 % | $ 8.72 B | ||
|
ResMed
RMD
|
744 M | $ 212.65 | -1.99 % | $ 31.1 B | ||
|
AtriCure
ATRC
|
78.5 M | $ 27.56 | -3.23 % | $ 1.32 B | ||
|
Harvard Bioscience
HBIO
|
20.8 M | $ 6.25 | -3.1 % | $ 277 M | ||
|
NeuroMetrix
NURO
|
1.35 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
62 M | $ 10.59 | -3.55 % | $ 433 M | ||
|
Becton, Dickinson and Company
BDX
|
3.89 B | $ 145.34 | -2.78 % | $ 41.8 B | ||
|
Nephros
NEPH
|
2.47 M | $ 3.27 | -1.51 % | $ 34 M | ||
|
OraSure Technologies
OSUR
|
31.1 M | $ 2.95 | -2.16 % | $ 217 M | ||
|
Repligen Corporation
RGEN
|
202 M | $ 112.82 | -3.93 % | $ 6.29 M |